Clinical Trials on Severe Head Trauma

Total 19623 results

Abela Pharmaceuticals, Inc.
Ohio State University; University of California, Irvine; Dr. Mahajan's Hospital...

Unknown

Controlled Trial of ABELADRUG200 in Closed, Severe Head Injury (ABELADRUG200)

Severe Head Trauma

United States
Makerere University

Completed

Early Tracheostomy Versus Standard of Care in Patients With Severe Head Injury (E-Trac)

Severe Head Injury

Uganda
University Hospital, Angers

Unknown

High Dose Hyperoncotic Serum Albumin for the Treatment of the Acute Phase of Severe Head Injury

Severe Head Injury

France
Second Affiliated Hospital, School of Medicine,...

Completed

Author-Wang Ping-- Research：Application of Ultrasonic Guided Puncture in Blood Collection in Patients With Severe Trauma

Severe Trauma

China
Hospices Civils de Lyon

Completed

Predictors of Hypofibrinogenemia in Severe Trauma

Severe Trauma

France
University Hospital, Brest

Unknown

Study of PbiO2 Variation by Body Temperature and Capnia in Severe Head Trauma Patients Treated With Targeted Temperature Control (TODAY)

Severe Brain Injury

France
Sanofi Pasteur, a Sanofi Company

Completed

Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine

Yellow Fever | Dengue | Dengue Fever | Dengue Hemorrhagic Fever

United States
University Hospital, Angers

Recruiting

Study Evaluating the Potential Impact of a Hemorrhagic Risk Stratification Score in Patients With Mild Head Trauma (TCL)

Head Injury Trauma

France
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia

Dengue | Dengue Fever | Dengue Hemorrhagic Fever

Indonesia, Philippines, Malaysia, Thailand, Vietnam
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Tetravalent Dengue Vaccine in Healthy Adults in Australia

Dengue Fever | Dengue Hemorrhagic Fever

Australia
Sanofi Pasteur, a Sanofi Company

Completed

Association of Host Genetics With Vaccine Efficacy and Study of Immune Correlates of Risk From a Tetravalent Dengue Vaccine

Dengue Fever | Dengue Haemorrhagic Fever

Thailand
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India

Dengue | Dengue Fever | Dengue Hemorrhagic Fever

India
Sanofi Pasteur, a Sanofi Company

Completed

Long-Term Study of Hospitalized Dengue & Safety in Thai Children Included in a Tetravalent Dengue Vaccine Efficacy Study

Dengue | Dengue Fever | Dengue Hemorrhagic Fever

Thailand
Sanofi Pasteur, a Sanofi Company

Terminated

Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects

Dengue Fever | Dengue Hemorrhagic Fever

Philippines
Sanofi

Completed

Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia

Dengue Fever | Dengue Hemorrhagic Fever

Malaysia
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America

Dengue | Dengue Fever | Dengue Hemorrhagic Fever

Colombia, Puerto Rico, Brazil, Honduras, Mexico
Sanofi

Completed

A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the Philippines

Dengue Fever | Dengue Hemorrhagic Fever

Philippines
Sanofi Pasteur, a Sanofi Company

Active, not recruiting

Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue Vaccine

Dengue Fever | Dengue Hemorrhagic Fever

Brazil, Mexico
Sanofi Pasteur, a Sanofi Company

Completed

Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers

Yellow Fever | Dengue | Dengue Hemorrhagic Fever

Peru, Colombia
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of Different Vaccination Schedules of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of Age

Dengue Fever | Dengue Hemorrhagic Fever

Colombia, Philippines
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose Schedule

Dengue Fever | Dengue Hemorrhagic Fever

Brazil, Colombia, Honduras, Mexico, Puerto Rico
Sanofi Pasteur, a Sanofi Company

Completed

Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children

Dengue | Dengue Fever | Dengue Hemorrhagic Fever

India
Queen Mary University of London

Completed

Severe Head Injury Brain Analysis (SHIBA)

Brain Injury Traumatic Severe

United Kingdom
Chang, Steve S., M.D.
Santa Barbara Cottage Hospital; Accumetrics, Inc.

Completed

Platelet Function Analysis in Head Trauma: ASA/Plavix (ASA/Plavix)

Head Injury Trauma Blunt

United States
Assistance Publique - Hôpitaux de Paris

Unknown

Emotional and Social Impact on the Relatives of Hospitalized Children for Severe Trauma (RESPET)

Severe Trauma

France
Sanofi

Completed

Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the US

Dengue Fever | Dengue Hemorrhagic Fever | Dengue Virus

United States
Sanofi

Completed

Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult Subjects

Dengue | Dengue Fever | Dengue Hemorrhagic Fever | Dengue Virus

Australia
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America

Dengue | Dengue Fever | Dengue Hemorrhagic Fever | Dengue Virus

Puerto Rico, Colombia, Mexico, Honduras
Medstar Health Research Institute

Not yet recruiting

Biomarkers in Concussion

Concussion, Mild | Concussion, Severe | Concussion, Intermediate
Milton S. Hershey Medical Center
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

The CDR Implementation Trial

Pediatric Abusive Head Trauma

United States
Sports Surgery Clinic, Santry, Dublin

Completed

Assessment of the Effects of Concussion on Adolescent Rugby Union Players

Concussion, Mild | Concussion, Severe | Concussion, Intermediate

Ireland
University of Washington
National Institute of General Medical Sciences (NIGMS)

Completed

Immune-cell Membrane Trafficking

Severe Trauma

United States
Duke University

Completed

Assessment of InfraScanner 2000™ in Detecting Subdural and Epidural Hematomas

Head Injuries, Closed | Head Trauma | Head Injuries | Craniocerebral Injuries | Crushing Skull Injury | Head Injuries, Multiple | Head Trauma,Closed | Head Trauma Injury | Head Trauma, Penetrating | Head Injury, Minor | Head Injury Major | Head Injury, Open | Injuries, Craniocerebral | Injuries, Head | Multiple Head... and other conditions

United States
University Hospital, Grenoble
University Hospital, Clermont-Ferrand

Recruiting

EffecT of eARly analGesia With Erector Spinae Plane Block to Reduce Ventilation After Severe Chest Trauma (TARGET)

Severe Chest Trauma

France
University Hospital, Strasbourg, France

Not yet recruiting

Diagnostic Performance of the S100B Protein in the Prognosis of Patients With Mild Head Trauma With Risk of Complications in Patients Over 65 Years Old.

Mild Head Trauma With Risk of Complications
Hospital Departamental de Villavicencio
Cooperative University of Colombia

Not yet recruiting

Trauma Registry in Villavicencio, Colombia (TRaVi)

Trauma | Severe Trauma | Polytrauma | Registries | Trauma Blunt | Penetrating Wounds

Colombia
Nantes University Hospital

Completed

Validation of the PECARN Clinical Decision Rule for Children With Minor Head Trauma

Head Injury

France
Sanofi Pasteur, a Sanofi Company

Completed

Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects

Dengue Fever | Dengue Hemorrhagic Fever | Dengue Virus | Dengue Disease

Vietnam
Sanofi Pasteur, a Sanofi Company

Completed

Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years

Dengue Fever | Dengue Hemorrhagic Fever | Dengue Virus | Dengue Diseases

Peru
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil®

Dengue Fever | Dengue Hemorrhagic Fever | Human Papillomavirus Disease

Malaysia
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix®

Dengue Fever | Dengue Hemorrhagic Fever | Human Papillomavirus Disease

Mexico
Sanofi Pasteur, a Sanofi Company

Completed

Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore

Dengue Fever | Dengue Hemorrhagic Fever | Dengue Virus | Dengue Diseases

Singapore
Duke University

Completed

Assessment of InfraScanner 2000™ in Detecting Subdural and Epidural Hematomas

Head Injuries, Closed | Head Trauma | Head Injuries | Craniocerebral Injuries | Crushing Skull Injury | Head Injuries, Multiple | Head Trauma,Closed | Head Trauma Injury | Head Trauma, Penetrating | Head Injury, Minor | Head Injury Major | Head Injury, Open | Injuries, Craniocerebral | Injuries, Head | Multiple Head... and other conditions

United States, Uganda
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of Formulations of Dengue Vaccines in Healthy Flavivirus-Naïve Adults

Dengue Fever | Dengue Hemorrhagic Fever | Dengue Virus | Dengue Diseases

Mexico
Sanofi Pasteur, a Sanofi Company

Completed

Efficacy and Safety of Dengue Vaccine in Healthy Children

Dengue Fever | Dengue Hemorrhagic Fever | Dengue Virus | Dengue Diseases

Thailand
POLYSAN Scientific & Technological Pharmaceutical...

Recruiting

International Trial of Efficacy of Cytoflavin in Head Trauma (MITRA)

Head Trauma,Closed

Russian Federation
Boston Children's Hospital
University of Colorado, Denver

Completed

The Effects of a Sub-maximal Exercise Program on Adolescents Who Sustained a Concussion

Concussion, Mild | Concussion, Brain | Concussion, Severe | Exertion; Excess

United States
Wake Forest University Health Sciences
Mind and Life Institute, Hadley, Massachusetts

Completed

A Meditation Intervention on Subconcussive Head Impacts

Head Injury Trauma

United States
Assiut University

Unknown

Decompressive Craniectomy Following Trauma

Head Injury Trauma

Egypt
BrainScope Company, Inc.

Completed

Objective Brain Function Assessment of mTBI/Concussion in High School Athletes (AheadCAS-HS)

Brain Injuries, Traumatic | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion, Intermediate

United States

Clinical Trials on Severe Head Trauma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations